Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$73,501
+$32,106 QoQ
Shares Held
469
+73.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,405
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AdvisorNet Financial, Inc holds $20,577,968 across 14 Drug Manufacturers - General names. NVS ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,169 | $3,852,470 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
27,109 | $3,424,951 | |
| 3 | LLY |
ELI LILLY & Co
|
2,556 | $3,065,743 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
38,342 | $2,209,266 | |
| 5 | AZN |
Astrazeneca PLC
|
11,574 | $2,194,661 | |
| 6 | ABBV |
AbbVie Inc.
|
6,595 | $1,659,565 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,405 | $1,337,042 | |
| 8 | GSK |
GSK plc
|
17,988 | $942,930 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,501 | 469 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $41,395 | 271 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $44,945 | 326 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $23,852 | 186 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $41,869 | 346 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $42,473 | 381 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $33,766 | 347 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $37,611 | 327 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $34,812 | 327 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $31,533 | 326 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $35,137 | 348 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $6,111 | 60 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $50,253 | 498 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $47,196 | 513 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $46,720 | 515 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $58,755 | 773 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $181,401 | 2,146 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $93,804 | 1,069 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $84,758 | 969 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $64,933 | 794 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $81,659 | 895 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $67,956 | 795 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $87,631 | 928 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $80,872 | 930 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $85,593 | 980 | Shares | Sole | 2020-08-26 | |
| 2020-03-31 | $90,447 | 1,097 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||